Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Jacob

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|February 26, 2011
Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan arrayFrancis Jacob, Darlene R Goldstein, Nicolai V Bovin, et al.
Plos One|December 3, 2020
Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesionManuela Estermann, Yen-Lin Huang, Dedy Septiadi, et al.
Analytical Chemistry|July 2, 2024
Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry ImagingCécile Cumin, Lindsay Gee, Thomas Litfin, et al.
Critical Reviews in Oncology/Hematology|April 4, 2026
Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practiceMartin Heidinger, Giuseppe Caruso, Ricardo Coelho, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>161</sup>Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with <sup>177</sup>Lu in Preclinical Models of Ovarian CancerTihomir Zh Todorov, Ricardo Coelho, Sharon Dellea, et al.
Cancer Cell|March 15, 2011
URI is an oncogene amplified in ovarian cancer cells and is required for their survivalJean-Philippe Theurillat, Stefan Christian Metzler, Nico Henzi, et al.
Scientific Reports|March 31, 2017
Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cellsShahidul Alam, Merrina Anugraham, Yen-Lin Huang, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
Plos One|February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patientsFrancis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
Biomaterials|January 23, 2023
A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasisManuela Estermann, Ricardo Coelho, Francis Jacob, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|February 26, 2011
Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan arrayFrancis Jacob, Darlene R Goldstein, Nicolai V Bovin, et al.
Plos One|December 3, 2020
Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesionManuela Estermann, Yen-Lin Huang, Dedy Septiadi, et al.
Analytical Chemistry|July 2, 2024
Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry ImagingCécile Cumin, Lindsay Gee, Thomas Litfin, et al.
Critical Reviews in Oncology/Hematology|April 4, 2026
Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practiceMartin Heidinger, Giuseppe Caruso, Ricardo Coelho, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>161</sup>Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with <sup>177</sup>Lu in Preclinical Models of Ovarian CancerTihomir Zh Todorov, Ricardo Coelho, Sharon Dellea, et al.
Cancer Cell|March 15, 2011
URI is an oncogene amplified in ovarian cancer cells and is required for their survivalJean-Philippe Theurillat, Stefan Christian Metzler, Nico Henzi, et al.
Scientific Reports|March 31, 2017
Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cellsShahidul Alam, Merrina Anugraham, Yen-Lin Huang, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
Plos One|February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patientsFrancis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
Biomaterials|January 23, 2023
A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasisManuela Estermann, Ricardo Coelho, Francis Jacob, et al.
Pageof 7